Literature DB >> 10191996

Laxative withdrawal in eating disorders: treatment protocol and 3 to 20-month follow-up.

P Colton1, D B Woodside, A S Kaplan.   

Abstract

OBJECTIVE: This article describes a treatment protocol for laxative withdrawal and presents some preliminary information about response to treatment at 3 to 20-month follow-up.
METHOD: Patients were contacted 3 to 20 months after admission and evaluated with a shortened form of the Eating Disorders Examination (EDE).
RESULTS: Fifty-seven percent of patients were abstinent from laxatives at follow-up and there were significant reductions in laxative-related symptom variables. Abstinence from laxatives was not accompanied by any other changes in eating behavior and was not associated with any pretreatment variables that were assessed. DISCUSSION: It appears to be feasible to withdraw patients from laxatives as an isolated intervention with a reasonably high rate of success.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10191996     DOI: 10.1002/(sici)1098-108x(199904)25:3<311::aid-eat9>3.0.co;2-l

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  5 in total

Review 1.  Laxative abuse: epidemiology, diagnosis and management.

Authors:  James L Roerig; Kristine J Steffen; James E Mitchell; Christie Zunker
Journal:  Drugs       Date:  2010-08-20       Impact factor: 9.546

Review 2.  Nutritional interventions for individuals with bulimia nervosa.

Authors:  S J Salvy; L McCargar
Journal:  Eat Weight Disord       Date:  2002-12       Impact factor: 4.652

3.  Medical complications of bulimia nervosa and their treatments.

Authors:  Katherine Sachs; Philip S Mehler
Journal:  Eat Weight Disord       Date:  2015-07-14       Impact factor: 4.652

4.  A blinded laxative taper for patients with eating disorders.

Authors:  J Harper; M Leung; C L Birmingham
Journal:  Eat Weight Disord       Date:  2004-06       Impact factor: 4.652

Review 5.  A clinical approach to the assessment and management of co-morbid eating disorders and substance use disorders.

Authors:  Claire Gregorowski; Soraya Seedat; Gerhard P Jordaan
Journal:  BMC Psychiatry       Date:  2013-11-07       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.